IKEDA YUJI 池田悠至

… Alternative Names

IKEDA Yuji 池田悠至

Less

Researcher Number	80713453
Other IDs
Affiliation (Current)	2025: 日本大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2020 – 2022: 日本大学, 医学部, 准教授 2018: 日本大学, 医学部, 助教 2017: 埼玉医科大学, 医学部, 助教 2014: 東京大学, 医学部附属病院, 助教 2013: 埼玉医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator WEE1阻害薬 / 子宮頸癌　WEE1阻害薬 / 子宮頸癌 / Wee1阻害薬 / アンチゲン / ペプチドワクチン / 婦人科癌 / 免疫療法 / がん精巣抗原 / PI3K/ｍTOR阻害薬 … More / CDK4/6阻害薬 / 放射線治療 / TP53 / PI3K経路 / 子宮体癌 / CDK4/6 Less

Effect of Wee1 inhibitors on human papilloma virus-related cervical cancerPrincipal Investigator
- Principal Investigator
  
  IKEDA Yuji
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Nihon University
Identification of paptide vaccine target in gynecologic cancer based on mRNA sewquencingPrincipal Investigator
- Principal Investigator
  
  IKEDA Yuji
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Nihon University
  Saitama Medical University
Effect of CDK4/6 inhibitor in endometrial cancerPrincipal Investigator
- Principal Investigator
  
  IKEDA Yuji
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  The University of Tokyo
  Saitama Medical University

All 2019 2018 2017 2015 2014 Other

All Journal Article Presentation

[Journal Article] Effective Screening of T cells Recognizing Neoantigens and Construction of T-cell Receptor-engineered T cells2018
- Author(s)
  Kato T, Matsuda T, Ikeda Y, Park JH, Leisegang M, Yoshimura S, Hikichi T, Harada M, Zewde M, Sato S, Hasegawa K, Kiyotani K, Nakamura Y
- Journal Title
  
  Oncotarget
  
  Volume: 9(13) Issue: 13 Pages: 11009-11019
- DOI
  10.18632/oncotarget.24232
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865
[Journal Article] Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer2018
- Author(s)
  Hasegawa K, Ikeda Y, Kunugi Y, Kurosaki A, Imai Y, Kohyama S, Nagao S, Kozawa E, Yoshida K, Tsunoda T, Nakamura Y, Fujiwara K.
- Journal Title
  
  J Immunother
  
  Volume: 41(4) Issue: 4 Pages: 201-207
- DOI
  10.1097/cji.0000000000000214
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865, KAKENHI-PROJECT-17K10607
[Journal Article] The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma2017
- Author(s)
  Matsushita H, Hasegawa K, Oda K, Yamamoto S, Nishijima A, Imai Y, Asada K, Ikeda Y, Karasaki T, Fujiwara K, Aburatani H, Kakimi K.
- Journal Title
  
  Oncoimmunology
  
  Volume: 6(8)
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865
[Journal Article] Characterization of the cryoablation-induced immune response in kidney cancer patients2017
- Author(s)
  Kato T, Iwasaki T, Uemura M, Nagahara A, Higashihara H, Osuga K, Ikeda Y, Kiyotani K, Park JH, Nonomura N, Nakamura Y.
- Journal Title
  
  Oncoimmunology
  
  Volume: 6(7)
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865
[Journal Article] Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer2017
- Author(s)
  Ikeda Y, Kiyotani K, Yew PY, Sato S, Imai Y, Yamaguchi R, Miyano S, Fujiwara K, Hasegawa K, Nakamura Y
- Journal Title
  
  Oncol Rep
  
  Volume: 37(5) Issue: 5 Pages: 2603-2610
- DOI
  10.3892/or.2017.5536
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16865, KAKENHI-PLANNED-15H05912, KAKENHI-PROJECT-15H02775, KAKENHI-PROJECT-15K00399
[Journal Article] Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers2017
- Author(s)
  Kato T, Park JH, Kiyotani K, Ikeda Y, Miyoshi Y, Nakamura Y.
- Journal Title
  
  Oncotarget
  
  Volume: 8(37) Issue: 37 Pages: 62029-62038
- DOI
  10.18632/oncotarget.18790
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865
[Journal Article] Characterization of the tumor T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck2017
- Author(s)
  Saloura V, Fatima A, Zewde M, Kiyotani K, Brisson RJ, Park JH, Ikeda Y, Vougiouklakis T, Bao R, Seiwert TY, Cipriani NA, Lingen MW, Vokes EE, Nakamura Y.
- Journal Title
  
  Clin Cancer Res
  
  Volume: 23(16) Issue: 16 Pages: 4897-4907
- DOI
  10.1158/1078-0432.ccr-17-0103
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16865
[Journal Article] PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-/VEGF pathway in endometrial cancer2015
- Author(s)
  Miyasaka A, Oda K, Ikeda Y, et al
- Journal Title
  
  Gynecologic Oncology
  
  Volume: in press
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25893229
[Presentation] Identification of endometrial cancer specific immunotherapeutic targets by comprehensive In Silico analysis2019
- Author(s)
  Yuji Ikeda
- Organizer
  American Association for Cancer Research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16865
[Presentation] Identification of endometrial cancer specific immunotherapeutic targets by comprehensive In Silico analysis2019
- Author(s)
  Yuji Ikeda
- Organizer
  第71回日本産婦人科学会
- Data Source
  KAKENHI-PROJECT-17K16865
[Presentation] Evaluation of neo-antigen specific CD8+ T cells in ascites of gynecologic cancer patients and identification of their T cell receptors using next generation sequencer2017
- Author(s)
  Yuji Ikeda, Kosei Hasegawa, Sho Sato, Keiichi Fujiwara, Yusuke Nakamura
- Organizer
  第69回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-17K16865
[Presentation] Aberrant expression of beta-catenin and cyclin D1 in endometrial cancer2014
- Author(s)
  Yuji Ikeda
- Organizer
  AACR annual meeting 2014
- Place of Presentation
  San Diego, USA
- Data Source
  KAKENHI-PROJECT-25893229
[Presentation] CDK4/6 specific activity as a novel biomaker for prognosis and chemo-sensitivity　in endometrial cancer.
- Author(s)
  Yuji Ikeda, Katsutoshi Oda, Hideki Ishihara, Osamu Wada-Hiraike, Aki Miyasaka, Tomoko Kashiyama, Takahiro Kohso, Kanako Inaba, Tomohiko Fukuda, Kenbun Sone, Yoko Matsumoto, Takahiro Arimoto, Kei Kawana, Daisuke Aoki, Yutaka Osuga, & Tomoyuki Fujii
- Organizer
  2014 The American college of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting
- Place of Presentation
  Chicago
- Year and Date
  2014-04-26 – 2014-04-30
- Data Source
  KAKENHI-PROJECT-25893229

1. 清谷一馬 (30433642)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

IKEDA YUJI 池田 悠至

IKEDA Yuji 池田 悠至

Research Projects

Research Products

Co-Researchers

Effect of Wee1 inhibitors on human papilloma virus-related cervical cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of paptide vaccine target in gynecologic cancer based on mRNA sewquencingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effect of CDK4/6 inhibitor in endometrial cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Effective Screening of T cells Recognizing Neoantigens and Construction of T-cell Receptor-engineered T cells2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma2017

Author(s)

Journal Title

Data Source

[Journal Article] Characterization of the cryoablation-induced immune response in kidney cancer patients2017

Author(s)

Journal Title

Data Source

[Journal Article] Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Characterization of the tumor T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-&#61537;/VEGF pathway in endometrial cancer2015

Author(s)

Journal Title

Data Source

[Presentation] Identification of endometrial cancer specific immunotherapeutic targets by comprehensive In Silico analysis2019

Author(s)

Organizer

Data Source

[Presentation] Identification of endometrial cancer specific immunotherapeutic targets by comprehensive In Silico analysis2019

Author(s)

Organizer

Data Source

[Presentation] Evaluation of neo-antigen specific CD8+ T cells in ascites of gynecologic cancer patients and identification of their T cell receptors using next generation sequencer2017

Author(s)

Organizer

Data Source

[Presentation] Aberrant expression of beta-catenin and cyclin D1 in endometrial cancer2014

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] CDK4/6 specific activity as a novel biomaker for prognosis and chemo-sensitivity in endometrial cancer.

Author(s)

Organizer

IKEDA YUJI 池田悠至

IKEDA Yuji 池田悠至

[Journal Article] PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-/VEGF pathway in endometrial cancer2015

[Presentation] CDK4/6 specific activity as a novel biomaker for prognosis and chemo-sensitivity　in endometrial cancer.